United Therapeutics Corporation
1110 Spring Street
Silver Spring
Maryland
20910
United States
Tel: 301-608-9292
Fax: 301-608-9291
Website: http://www.unither.com/
261 articles with United Therapeutics Corporation
-
United Therapeutics Corporation to Present at Goldman Sachs 40th Annual Global Healthcare Conference
6/5/2019
United Therapeutics Corporation announced that James Edgemond, Chief Financial Officer and Treasurer of United Therapeutics, will provide an overview and update on the company's business at the Goldman Sachs 40th Annual Global Healthcare Conference in Rancho Palos Verdes, CA.
-
United Therapeutics Corporation To Present at Jefferies 2019 Healthcare Conference
5/28/2019
United Therapeutics Corporation announced that James Edgemond, Chief Financial Officer and Treasurer of United Therapeutics, will provide an overview and update on the company's business at the Jefferies 2019 Healthcare Conference in New York City.
-
United Therapeutics And DEKA Announce FDA Clearance Of The Unity Subcutaneous Delivery System For Remodulin®
5/7/2019
United Therapeutics Corporation and DEKA Research & Development Corp.
-
United Therapeutics Corporation Reports First Quarter 2019 Financial Results
5/1/2019
United Therapeutics Corporation announced its financial results for the quarter ended March 31, 2019.
-
United Therapeutics Announces FDA Approval Of XPS™ And Steen Solution™ Used To Perform Centralized Ex-Vivo Lung Perfusion Services
4/29/2019
United Therapeutics Corporation announced that its collaborator, XVIVO Perfusion, Inc., a subsidiary of XVIVO Perfusion AB, has received Premarket Approval from the U.S. Food and Drug Administration for the products XPS™ and STEEN Solution™.
-
United Therapeutics Corporation To Report First Quarter 2019 Financial Results Before The Market Opens On Wednesday, May 1, 2019
4/24/2019
United Therapeutics Corporation announced that it will report its first quarter 2019 financial results before the market opens on Wednesday, May 1, 2019.
-
Maryland-based United Therapeutics said Sandoz has had eight years to ensure it had its own delivery system in place for its generic pulmonary arterial hypertension medication.
-
United Therapeutics Issues Statement In Response To Meritless Lawsuit
4/18/2019
United Therapeutics Corporation was named as a defendant, along with Smiths Medical ASD, Inc., in a lawsuit filed in federal court by Sandoz Inc.
-
The biopharma and medtech ecosystem in New Hampshire is growing thanks, in part, to state-supported tax exemptions and an increasing number of regenerative medicine manufacturing companies setting up shop in the Granite State.
-
The study, which uses data gathered from Great Places to Work, points to the company’s openness from its leadership and the treatment of its employees as the primary reason it took the top spot.
-
United Therapeutics Announces BEAT Study of Esuberaprost Does Not Meet Primary Endpoint
4/8/2019
United Therapeutics Corporation announced that the BEAT clinical study of esuberaprost tablets in patients suffering from pulmonary arterial hypertension did not meet its primary endpoint of delayed time to first clinical worsening event.
-
Silver Spring, Maryland-based United Therapeutics announced that its esuberaprost tablet did not meet its primary endpoint in the BEAT Phase III clinical trial in patients with pulmonary arterial hypertension (PAH).
-
United Therapeutics Corporation to Present at Oppenheimer 29th Annual Healthcare Conference
3/12/2019
United Therapeutics Corporation announced that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of United Therapeutics, will provide an overview and update on the company's business at the Oppenheimer 29th Annual Healthcare Conference in New York City.
-
United Therapeutics Corporation To Present At Cowen And Company 39th Annual Health Care Conference
3/4/2019
United Therapeutics Corporation announced that James Edgemond, Chief Financial Officer and Treasurer of United Therapeutics, will provide an overview and update on the company's business at the Cowen and Company 39th Annual Health Care Conference in Boston, Massachusetts.
-
United Therapeutics Corporation Reports 2018 Fourth Quarter And Annual Financial Results
2/27/2019
United Therapeutics Corporation announced its financial results for the fourth quarter and year ended December 31, 2018.
-
United Therapeutics Corporation To Report Fourth Quarter And Annual 2018 Financial Results Before The Market Opens On Wednesday, February 27, 2019
2/20/2019
United Therapeutics Corporation announced that it will report its fourth quarter and annual 2018 financial results before the market opens on Wednesday, February 27, 2019.
-
Survival Data From FREEDOM-EV Study of Orenitram Presented at the Pulmonary Vascular Research Institute Annual World Congress
2/1/2019
United Therapeutics Corporation today announced that key data from the FREEDOM-EV study of Orenitram® extended-release tablets were shared during an oral presentation at the Pulmonary Vascular Research Institute Annual World Congress on Pulmonary Vascular Disease in Barcelona, Spain.
-
United Therapeutics Announces Closing Of License Agreement With Arena Pharmaceuticals For Ralinepag
1/25/2019
United Therapeutics Corporation announced the closing of the transactions contemplated by its license agreement with Arena Pharmaceuticals, Inc. (Nasdaq: ARNA).
-
Arena Pharmaceuticals Announces Closing of Global License Agreement with United Therapeutics for Ralinepag
1/25/2019
Arena Pharmaceuticals, Inc. announced the closing of the global license agreement with United Therapeutics Corporation for the Arena-discovered, Phase 3 investigational drug candidate ralinepag, a next-generation, oral, selective and potent prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension
-
United Therapeutics Corporation To Present At 37th Annual J.P. Morgan Healthcare Conference
12/31/2018
United Therapeutics Corporation announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of United Therapeutics, will provide an overview and update on the company's business at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, California.